摘要
目的 分析宫腔镜手术联合芬吗通口服治疗宫腔残留效果及对子宫内膜厚度、不良妊娠发生率的影响。方法 选取2019年10月—2021年10月滕州市中心人民医院收治的84例宫腔残留患者为研究对象,随机分为对照组和观察组,每组42例。对照组患者接受宫腔镜手术联合补佳乐药物治疗,观察组患者接受宫腔镜手术联合芬吗通治疗。比较两组不同时间段的子宫内膜厚度、月经治疗效果及不良妊娠结局发生率。结果 治疗后15 d、治疗后1个月及2个月,观察组子宫内膜厚度均大于对照组,差异均有统计学意义(P<0.05)。观察组月经治疗总有效率为97.62%,高于对照组的83.33%,差异有统计学意义(P<0.05)。观察组不良妊娠结局发生率为4.76%,低于对照组的19.05%,差异有统计学意义(P<0.05)。结论 给予宫腔残留患者宫腔镜手术联合芬吗通治疗,能够明显提升临床疗效,改善妊娠结局,减少子宫内膜厚度,为患者的疾病预后提供了保障,在临床治疗中具有推广及应用价值。
Objective To analyze the effect of hysteroscopic surgery combined with oral Femoston in the treatment of residual uterine cavity and its effect on endometrial thickness and incidence of adverse pregnancy. Methods A total of 84 patients with residual uterine cavity treated in Tengzhou Central People’s Hospital from October 2019 to October 2021 were selected as the research objects,and randomly divided into control group and observation group,with 42 cases in each group. The patients in the control group received hysteroscopic surgery combined with Bugatol,while the patients in the observation group received hysteroscopic surgery combined with Femoston. The endometrial thickness,the effect of menstrual therapy and the incidence of adverse pregnancy outcomes were compared between the two groups at different time periods. Results At 15 days,1 month and 2 months after treatment,the endometrial thickness in the observation group was greater than those in the control group,and the differences were statistically significant(P<0.05). The total effective rate of menstruation treatment in the observation group was 97.62%,which was higher than 83.33% in the control group,and the difference was statistically significant(P<0.05).The incidence of adverse pregnancy outcome in the observation group was 4.76%,which was lower than19.05% in the control group,and the difference was statistically significant(P <0.05). Conclusion Hysteroscopic surgery combined with Femoston treatment for patients with residual uterine cavity could significantly improve the clinical efficacy,improve pregnancy outcomes,reduce endometrial thickness,provide guarantee for the prognosis of patients,which had promotion and application value in clinical treatment.
作者
魏艳秋
丁佰娟
崔秀娟
WEI Yan-qiu;DING Bai-juan;CUI Xiu-Juan(Department of First Gynecology,Tengzhou Central People's Hospital,Tengzhou Shandong Province 277500,China)
出处
《中国城乡企业卫生》
2023年第2期131-133,共3页
Chinese Journal of Urban and Rural Enterprise Hygiene
基金
2019年济宁医学院教师科研扶持基金立项项目(JYFC2019FKJ093)。
关键词
宫腔镜手术
芬吗通
宫腔残留
Hysteroscopic surgery
Femoston
Residual uterine cavity